Company Filing History:
Years Active: 2014
Title: Lien-Hsiang Chang: Innovator in Tubulin Inhibitors
Introduction
Lien-Hsiang Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target tubulin polymerization. His work is crucial for advancing treatments for various diseases, including cancers and other conditions associated with abnormal cell proliferation.
Latest Patents
Lien-Hsiang Chang holds a patent for "Tubulin inhibitors and methods of using the same." This patent includes compounds represented by the formula (I) or pharmaceutically acceptable salts thereof. These compounds are designed to inhibit tubulin polymerization by binding at the colchicine binding site. They are particularly useful in the treatment of tumors or mitotic diseases such as cancers, gout, and other conditions associated with abnormal cell proliferation. He has 1 patent to his name.
Career Highlights
Chang is affiliated with the Development Center for Biotechnology, where he continues to innovate and contribute to the field. His research focuses on creating effective treatments that can improve patient outcomes in oncology and related areas.
Collaborations
Some of his notable coworkers include Meng-Hsin Chen and Shih-Hsien Chuang, who collaborate with him on various research projects.
Conclusion
Lien-Hsiang Chang's work in developing tubulin inhibitors represents a significant advancement in biotechnology. His contributions are vital for the ongoing fight against cancer and other diseases related to cell proliferation.